ESR1 and breast carcinoma: For 44 Taiwanese breast cancers with survival data, we did find a trend toward good prognosis for luminal A subtype and worse prognosis for luminal B and HER2-enriched subtype, and a survival benefit of basal-like over HER2-enriched subtype was also observed, especially when subgroup analysis was performed according by IHC ER status.